Under Armour, Inc. filed its second-quarter fiscal 2027 earnings press release on November 6, 2026, reporting unaudited results for the three months ended September 30, 2026, including a 7 percent revenue decline and updated full-year guidance.
Calumet, Inc. filed its third-quarter 2026 earnings release on November 6, 2026, reporting net income of $273.3 million and continued debt reduction across its three operating segments for the period ended September 30, 2026.
Vistra Corp. (NYSE:VST) reported its third quarter 2026 financial results on November 6, 2026, disclosing GAAP net income of $1,140 million and Ongoing Operations Adjusted EBITDA of $2,378 million, while also raising its full-year 2026 guidance and initiating 2027 guidance ranges.
Tang Heng, executive vice president of NIP Group Inc., filed a Schedule 13D on November 6, 2026, disclosing beneficial ownership of 53,337,563 ordinary shares following the vesting of restricted shares on October 30, 2026.
Starwood Property Trust, Inc. (NYSE:STWD) released its third-quarter 2026 earnings press release on November 6, 2026, reporting results for the fiscal quarter ended September 30, 2026.
Applied Optoelectronics, Inc. filed an 8-K on November 6, 2026, disclosing that its Compensation Committee granted inducement equity awards covering 1,346 shares of common stock to three new employees, with a grant date of November 2, 2026.
Bausch Health Companies Inc. and its Salix Pharmaceuticals unit disclosed the presentation of a real-world research poster at The Liver Meeting 2026 in Denver, Colorado, on November 6, 2026, covering mortality and rehospitalization outcomes in patients hospitalized with severe alcohol-associated hepatitis.
Brookdale Senior Living Inc. (NYSE:BKD) released its third-quarter 2026 earnings results on November 6, 2026, reporting a narrowed net loss and double-digit Adjusted EBITDA growth alongside updated full-year 2026 guidance.
Elanco Animal Health Incorporated filed its third quarter 2026 financial results on November 6, 2026, reporting revenue of $1.265 billion and raising its full year 2026 guidance across all key metrics.
Elanco Animal Health Incorporated (NYSE:ELAN) released findings from an October 2026 U.S. consumer survey of 2,018 adults on November 6, 2026, showing sustained or increased pet health spending among the vast majority of pet owners surveyed.